ANXIETY AND DEPRESSIVE DISORDERS DURING THE COVID-19 EPIDEMIC
ANXIETY AND DEPRESSIVE DISORDERS DURING THE COVID-19 EPIDEMIC
Tabeeva G.R.
For quotation:
Tabeeva G.R. Anxiety and depressive disorders during the COVID-19 epidemic // Behavioral
neurology. 2021. No. 2. pp. 24–32.
DOI 10.46393/2712-9675_2021_2_24_32
Annotation:
The novel coronavirus disease (COVID-19) pandemic is associated with a marked increase in the prevalence of depressive and anxiety disorders in the population. Among survivors of COVID-19, as well as among medical personnel working with these patients, the prevalence rates of anxiety and depressive disorders are even higher and significantly exceed levels recorded before the pandemic. The severity of anxiety and depressive disorders significantly affects the quality of life of a large category of people and aggravates the burden of the pandemic as a whole. Analysis
existing data on the possibilities of correcting anxiety and depression in these conditions is of particular importance for clinical practice.